Glucose, Lipid, and Blood Pressure Control in Australian Adults With Type 2 Diabetes
The 1999–2000 AusDiab
- Thomas M. Kemp, FRCP1,
- Elizabeth L.M. Barr, MPH2,
- Paul Z. Zimmet, AO, MD, PHD2,
- Adrian J. Cameron, MPH2,
- Timothy A. Welborn, AO, PHD3,
- Stephen Colagiuri, MD4,
- Patrick Phillips, MD5,
- Jonathan E. Shaw, MD2 and
- on behalf of the AusDiab Steering Committee
- 1Department of Medicine, Dewsbury & District Hospital, Dewsbury, West Yorkshire, U.K.
- 2International Diabetes Institute, Caulfield, Victoria, Australia
- 3Department of Medicine, University of Western Australia, Nedlands, Western Australia, Australia
- 4Department of Endocrinology, Diabetes and Metabolism, The Prince of Wales Hospital, Randwick, New South Wales, Australia
- 5Endocrinology Unit, North Western Adelaide Health Service, Queen Elizabeth Hospital, Woodville, South Australia, Australia
- Address correspondence and reprint requests to Elizabeth L.M. Barr, International Diabetes Institute, 250 Kooyong Rd., Caulfield, Victoria 3162, Australia. E-mail: lbarr{at}idi.org.au
The risk of diabetes complications can be reduced by tight control of blood glucose (1), serum lipids (2), and blood pressure (3,4). However, evidence from a limited number of studies (5–9) indicates that many people with type 2 diabetes do not achieve recommended targets for these factors. We examined levels of glucose, lipid, and blood pressure control in participants with type 2 diabetes taking part in the national population-based Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) (10) conducted during 1999–2000.
RESEARCH DESIGN AND METHODS
AusDiab was a national population-based survey of the general population and has been described in detail earlier (10). Diagnosis of diabetes was based on self-reported physician diagnosis of diabetes confirmed either by self-reported use of hypoglycemic drugs or results from a 75-g oral glucose tolerance test (11). Participants who started insulin treatment within 2 years of diagnosis were classified as having type 1 diabetes (if diabetes onset was at age ≥40 years; BMI also had to be <27 kg/m2). All other cases were classified as type 2 diabetes.
Fasting (≥9 h) serum total cholesterol, LDL and HDL cholesterol, and triglycerides were measured (Olympus AU600 analyzer; Olympus Optical, Tokyo, Japan). Total glycated hemoglobin analysis used high-performance liquid chromatography (Bio-Rad Variant Hemoglobin Testing System; Bio-Rad, Hercules, CA) with standardized conversion to HbA1c values …
